Compare CDMOs with pharmaceutical packaging and labeling capabilities including blister packaging, bottling, serialization, and clinical trial labeling.
494 companies listed
Packaging and labeling is the final manufacturing step before distribution. Primary packaging (blisters, bottles, vials, pouches) directly contacts or contains the product. Secondary packaging (cartons, inserts, cases) provides information and protection. Both must comply with regulatory requirements for labeling content, child resistance, and serialization/track-and-trace.
Serialization is now mandatory in most major markets. The Drug Supply Chain Security Act (DSCSA) in the US, EU Falsified Medicines Directive (FMD), and similar regulations globally require unique serial numbers on each unit, enabling track-and-trace through the distribution chain. CDMOs must have validated serialization lines integrated with their packaging operations.
United States
Aspire Pharmaceuticals (Aspire LLC) is a contract manufacturer specializing in softgel encapsulation and oral solid dosage forms. They offer proprietary technologies including GummiCore (gummy-centered softgels), Vecell Liposomes (liposomal delivery), and softgel manufacturing using tapioca, carrageenan, and gelatin. They also have FDA-approved inhaled and ophthalmic products in their portfolio.
France
Astrea Pharma is a CDMO founded with the purpose of building a customer-focused manufacturing network covering development to commercial supply. They acquired the Fontaine-les-Dijon solid dose manufacturing site from Recipharm and offer oral solid dose and aseptic manufacturing capabilities from development through commercial supply, with a focus on efficiency and value in the pharma supply chain.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.